what glp-1 drugs are fda approved for weight loss New Pill Foundayo (Orforglipron) Gets Approval Obesity FDA approves new GLP-1 weight

Nangaku M, Wanner C

This occurs because the underlying insulin resistance and beta-cell dysfunction remain unchanged

That's why we're genuinely excited about new research published in April 2025 that highlights GLP-1 receptor agonists (GLP-1 RAs)

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Even the smaller dose of orforglipron lowered HbA1c 0.24 percentage points more than the higher dose of semaglutide

PD and mitochondrial dysfunction Mitochondria are the most common organelles in eukaryotic cells, generating energy through cellular oxidative phosphorylation, converting adenosine diphosphate (ADP) to adenosine triphosphate (ATP), and providing energy for neurons